A new cancer-detecting tool uses tiny circuits made of DNA to identify cancer cells by the molecular signatures on their surface.
Duke University researchers fashioned the simple circuits from interacting strands of synthetic DNA that are tens of thousands of times finer than a human hair.
Unlike the circuits in a computer, these circuits work by attaching to the outside of a cell and analyzing it for proteins found in greater numbers on some cell types than others. If a circuit finds its targets, it labels the cell with a tiny light-up tag.
Because the devices distinguish cell types with higher specificity than previous methods, the researchers hope their work might improve diagnosis, and give cancer therapies better aim.
A team led by Duke computer scientist John Reif and his former Ph.D. student Tianqi Song described their approach in a recent issue of the Journal of the American Chemical Society.
Similar techniques have been used previously to detect cancer, but they’re more prone to false alarms — misidentifications that occur when mixtures of cells sport one or more of the proteins a DNA circuit is designed to screen for, but no single cell type has them all.
For every cancer cell that is correctly detected using current methods, some fraction of healthy cells also get mislabeled as possibly cancerous when they’re not.
Each type of cancer cell has a characteristic set of cell membrane proteins on its cell surface. To cut down on cases of mistaken identity, the Duke team designed a DNA circuit that must latch onto that specific combination of proteins on the same cell to work.
As a result they’re much less likely to flag the wrong cells, Reif said.
The technology could be used as a screening tool to help rule out cancer, which could mean fewer unnecessary follow-ups, or to develop more targeted cancer treatments with fewer side effects.
Each basic element of their DNA circuit consists of two DNA strands. The first DNA strand folds over and partially pairs up with itself to form a hairpin shape. One end of each hairpin is bound to a second strand of DNA that acts as a lock and tether, folding in such a way to fit a specific cell surface protein like a puzzle piece. Together these two strands act to verify that that particular protein is present on the cell surface.
To look for cancer, the circuit components are mixed with a person’s cells in the lab. If any cells are studded with the right combination of proteins, the complete circuit will attach. Adding a strand of “initiator” DNA then causes one of the hairpins to open, which in turn triggers another in a chain reaction until the last hairpin in the circuit is opened and the cell lights up.
Test runs of the device in test tubes in Reif’s lab showed it can be used to detect leukemia cells and to distinguish them from other types of cancer within a matter of hours, just by the strength of their glow.
The devices can be easily reconfigured to detect different cell surface proteins by replacing the tether strands, the researchers say. In the future, Reif plans to expand the device to release a small molecule that alerts the body’s immune system to attack the cancer cell.
The technology isn’t ready for prime time yet. The researchers say their DNA circuits require testing in more realistic conditions to make sure they still flag the right cells.
But it’s a promising step toward ensuring that cancer screens and therapies zero in on the right culprits.
Learn more: I.D. VERIFICATION, NOW FOR CANCER
The Latest Google Headlines on:
The Latest Bing News on:
- Recombinant DNA Technology Market Is Booming Worldwide (2021-2030) With COVID-19 Updates | Profacgen, Monsanto Companyon January 19, 2021 at 3:22 pm
MarketResearch.Biz –:An extensive and elaborate primary research on Global Recombinant DNA | eTurboNews | Trends | Travel News Online | ...
- DNA origami enables fabricating superconducting nanowireson January 19, 2021 at 8:02 am
The quest for ever-smaller electronic components led an international group of researchers to explore using molecular building blocks to create them. DNA is able to self-assemble into arbitrary ...
- CRISPR technology shown to dial down gene activity in bacteriaon January 19, 2021 at 7:31 am
In a series of experiments with laboratory-cultured bacteria, Johns Hopkins scientists have found evidence that there is a second role for the widely used gene-cutting system CRISPR-Cas9—as a genetic ...
- Global Anti-Counterfeit Packaging Market- Featuring Alien Technology LLC, AlpVision SA, and Applied DNA Sciences Inc. Among Otherson January 19, 2021 at 5:57 am
Technavio has announced its latest market research report titled Global Anti-Counterfeit Packaging Market 2020-2024 (Graphic: Business Wire) LONDON-- ( BUSINESS WIRE )--The anti-counterfeit packaging ...
- Recombinant DNA (rDNA) Technology Market : Business overview, Upcoming Trends and Top Company Analysis Forecast By 2025on January 19, 2021 at 12:25 am
The report offers overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts. Recombinant DNA ...
- Recombinant DNA Technology Market 2021- Global Trends, Key Growth, Demand, Analysis, Technology Trends to Forecast till 2023on January 17, 2021 at 11:51 pm
Overview The breakthroughs in genetic research have opened up new avenues for the development of recombinant DNA technology. Market reports connected with the healthcare industry have been made ...
- Why Applied DNA Sciences Is Up 30% Todayon January 15, 2021 at 11:53 am
Applied DNA Sciences (NASDAQ: APDN) shares are trading higher on reports the U.K. COVID strain could become the dominant strain in the U.S. The FDA last week reported the ...
- Scientists Write ‘Hello World’ in Bacterial DNA With Electricity and CRISPRon January 15, 2021 at 4:13 am
A study published on January 11 in the journal Nature Chemical Biology details how the researchers led by Columbia University systems biologist Harris Wang used electricity and the DNA editing tool ...
- Can New DNA Technology Help Track Down Killer Of Little Girl Who Inspired Amber Alert System, 25 Years Later?on January 14, 2021 at 10:39 am
A quarter-century after the murder of a 9-year-old Texas girl — a case that subsequently inspired the nationwide AMBER Alert system in missing children cases — investigators are still on the hunt for ...
- Kontakt.io Joins Cisco DNA Spaces to Expand BLE IoT Services for Cisco Customerson January 14, 2021 at 8:00 am
Kontakt.io today announced a new integration with the Cisco DNA Spaces platform to enable Bluetooth Low Energy (BLE) IoT solutions ...
The Latest Google Headlines on:
Targeted cancer treatments
The Latest Bing News on:
Targeted cancer treatments
- What I Wish I’d Known About Kidney Canceron January 19, 2021 at 2:46 pm
How to find support, get financial assistance, and more practical tips for managing a journey with kidney cancer from patients who have been through it.
- Lilly expands its cancer drug work with bet on dual-acting antibodieson January 19, 2021 at 9:17 am
An alliance with Merus, a Dutch biotech, continues Lilly's push to revitalize its oncology research under the leadership of former Loxo Oncology executives.
- AstraZeneca, Daiichi Sankyo push Enhertu closer to the blockbuster frontier with stomach cancer OKon January 19, 2021 at 7:05 am
Daiichi Sankyo and partner AstraZeneca have taken their HER2-targeted cancer drug Enhertu another step toward blockbuster land. The FDA cleared the med for use in HER2-positive stomach cancer patients ...
- AACR and MPM Oncology Charitable Foundation Announce Three Grants to Support Transformative Cancer Researchon January 19, 2021 at 6:39 am
Three grants for research that could transform cancer therapies have been awarded by the AACR- Transformative Cancer Research Grants Program, an innovative partnership between the American Association ...
- Pursuing Pairings of Targeted Agents and HMAs in AMLon January 19, 2021 at 6:02 am
Alison R. Sehgal, MD, discusses some of the novel approaches that have been adopted into practice and ongoing research building on the advances that have been made with targeted therapy.
- Unleashing the cancer-fighting gene TP53 in leukemia with a novel combination treatmenton January 19, 2021 at 5:41 am
Drugs that target the cancer-promoting proteins MDM2 and BET have been tried in acute myeloid leukemia (AML) but haven’t been all that effective on their own. In a new study, combining the two ...
- Global Cancer Supportive Care Market Report 2020: Unmet Needs and Opportunities for Various Indicationson January 19, 2021 at 1:58 am
The "Supportive Care in Cancer - Comprehensive Overview, Pipeline Products, Research and Development Strategies and Unmet ...
- Chemotherapy-Free Treatment Remains Unmet Need in Colorectal Canceron January 18, 2021 at 2:41 pm
Zev A. Wainberg, MD, explains the importance of having a chemotherapy-free option available for patients with colorectal cancer.
- Dr. Stiles on Treatment Advances Made in Early-Stage Lung Canceron January 18, 2021 at 10:05 am
Brendon Stiles, MD, discusses the roles of surgery, radiation, and chemotherapy in treatment for early-stage lung cancer.
- Relevant Trials Show Which Treatments Are Worth Using in HER2-Positive Breast Canceron January 16, 2021 at 8:43 am
Based Peer Perspectives Roundtable event, Ruta D. Rao, MD, discussed the case of 42-year-old woman with HER2-positive breast cancer.